Company: ELV
Filing Date: 2025-09-09
Form Type: 424B3
Source: 0001193125-25-199226
Chunk: 31

Company: Elevance Health, Inc.
Filing Date: 2025-09-09
Form: 424B3
Chunk 31
---
 Inc. and Mizuho Securities USA LLC are the representatives of the underwriters. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has agreed to purchase, severally and not jointly, the aggregate principal amount of notes listed next to its name in the following table:

| Underwriter                         |     |   |   Principal 
   Amount of 
  2028 Notes |     |   |   Principal 
   Amount of 
  2032 Notes |     |   |     Principal 
     Amount of 
    2036 Notes |     |   |   Principal 
   Amount of 
  2055 Notes |
|:------------------------------------|:----|:--|------------:|:----|:--|------------:|:----|:--|--------------:|:----|:--|------------:|
| BofA Securities, Inc.               |     | $ | 111,000,000 |     | $ | 111,000,000 |     | $ |   148,000,000 |     | $ |  74,000,000 |
| Deutsche Bank Securities Inc.       |     | $ | 108,750,000 |     | $ | 108,750,000 |     | $ |   145,000,000 |     | $ |  72,500,000 |
| Mizuho Securities USA LLC           |     | $ |  90,000,000 |     | $ |  90,000,000 |     | $ |   120,000,000 |     | $ |  60,000,000 |
| PNC Capital Markets LLC             |     | $ |  56,250,000 |     | $ |  56,250,000 |     | $ |    75,000,000 |     | $ |  37,500,000 |
| UBS Securities LLC                  |     | $ |  56,250,000 |     | $ |  56,250,000 |     | $ |    75,000,000 |     | $ |  37,500,000 |
| U.S. Bancorp Investments, Inc.      |     | $ |  56,250,000 |     | $ |  56,250,000 |     | $ |    75,000,000 |     |